Dora Kholodenko
Impact in
- Physiology top 0.5%
- Alzheimer's disease research and treatments
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Physiology 10
- Alzheimer's disease research and treatments 10
-
- Prion Diseases and Protein Misfolding 3
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Co-authors
- Kang Hu (2 shared papers)Lisa McConlogue (2 shared papers)Lennart Mucke (2 shared papers)Eliezer Masliah (2 shared papers)Gwen Tatsuno (2 shared papers)Kelly Johnson‐Wood (3 shared papers)Edward Rockenstein (1 shared paper)Gui-Qiu Yu (1 shared paper)
- Journals
- Alzheimer s & Dementia (2 papers)Journal of Biological Chemistry (2 papers)Neurodegenerative Diseases (1 paper)Journal of Neuroscience (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Dora Kholodenko
10 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Physiology 3.3k
- Neurology 753
- Biological Psychiatry 170
- Cellular and Molecular Neuroscience 1.2k
- Pharmacology 797
Countries citing papers authored by Dora Kholodenko
This map shows the geographic impact of Dora Kholodenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Kholodenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Kholodenko more than expected).
Fields of papers citing papers by Dora Kholodenko
This network shows the impact of papers produced by Dora Kholodenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Kholodenko. The network helps show where Dora Kholodenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Kholodenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation Hit paper breakdown → | 2000 | 1543 |
| 2 | Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models Hit paper breakdown → | 1999 | 927 |
| 3 | Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease Hit paper breakdown → | 1995 | 568 |
| 4 | 1998 | 369 | |
| 5 | 1997 | 243 | |
| 6 | 1997 | 156 | |
| 7 | 2008 | 55 | |
| 8 | 2010 | 4 | |
| 9 | 2010 | 3 | |
| 10 | 1996 | 3 |
About Dora Kholodenko
Dora Kholodenko is a scholar working on Physiology, Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience and Psychiatry and Mental health, having authored 10 papers that have together received 3.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (10 papers), Prion Diseases and Protein Misfolding (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Dementia and Cognitive Impairment Research (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Schizophrenia research and treatment (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper) and Neuroscience and Neuropharmacology Research (1 paper). The work is most often cited by research in Physiology (3.3k citations), Neurology (753 citations), Biological Psychiatry (170 citations), Cellular and Molecular Neuroscience (1.2k citations) and Pharmacology (797 citations). Dora Kholodenko has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Kang Hu, Lisa McConlogue, Lennart Mucke, Eliezer Masliah, Gwen Tatsuno, Kelly Johnson‐Wood, Edward Rockenstein, Gui-Qiu Yu, Margaret Mallory and Peter Seubert. Their work appears in journals such as Alzheimer s & Dementia, Journal of Biological Chemistry, Neurodegenerative Diseases, Journal of Neuroscience and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.